Company Profile | July 30, 2007

Siemens - The Future of Pharmaceutical Manufacturing

 

Life Sciences Industry Solutions

Searching for answers to meet the demands of an ever-changing market?

 

Siemens Hot Topics

 

News

 

SIPAT — The Software Heart Of PAT
Regulatory, market, scientific and technological forces are pitching pharmaceutical manufacturing towards rapid change in the next decade. Manufacturing efficiency and innovation is high on the change agenda with big gains to be secured by companies that innovate successfully.

Continuous Manufacturing
In the pharmaceutical industry, it is time to get serious about continuous production processes. After extensive research and development, continuous manufacturing is leaving the trial phase and getting ready for commercial deployment. Continuous production in compact, contained units that provide a high level of automation and require reduced manual intervention will pay off by delivering a wide range of benefits.

 

References and Case Studies

To View Events Please Click Here
 

About Siemens

Siemens AG (NYSE: SI) is a global powerhouse in electronics and electrical engineering, and operates in the industry, energy and healthcare sectors. For more than 160 years, Siemens has built a reputation for leading-edge innovation and the quality of its products, services and solutions. With 405,000 employees in 190 countries, Siemens reported worldwide sales of $102.9 billion in fiscal 2010. With its U.S. corporate headquarters in Washington, DC, Siemens in the USA reported sales of $19.9 billion and employs more than 60,000 people throughout all 50 states and Puerto Rico. For more information on Siemens in the United States, visit www.usa.siemens.com.